Thursday 14 June 2018

The Brewery, London EC1

News:

Sponsors

Headline sponsor:

Stifel_logo.png 

London branch:
150 Cheapside
London 
EC2V 6ET 

snclientserv@stifel.com 
www.stifel.com

 

Stifel 

Stifel is a US-incorporated, NYSE-listed institutional wealth manager and investment bank, focused on the middle market. It provides strategic advisory services to its clients in North America, Europe and Asia that include initiating, structuring and negotiating mergers, acquisitions and divestitures, as well as providing fairness opinions, valuation, and restructuring services. It raises equity and public and private debt for its clients through its institutional and retail brokerage network. Stifel has a strategic emphasis globally on the healthcare sector, with senior bankers focused across all products, based in Europe and North America.

www.stifel.com

Sponsors: 

 MCServices_175px.png

To contact one of our offices: 

Munich:
Bavariaring 26
80336 München, Germany
Phone +49-89-210228-0

Düsseldorf:
Kaiser-Friedrich-Ring 5
40545 Düsseldorf, Germany
Phone +49-211-529252-0

Or email us at:
contact@mc-services.eu 
www.mc-services.eu

 

MC Services AG 

MC Services AG is an international public relations and investor relations firm specialising in communications for the life sciences and healthcare sectors. A strong team of science, finance, media and communication experts with extensive industry experience positions MC Services as the leading life sciences agency in Europe. MC Services' long-standing clients include international public and private companies as well as venture capitalists and investment firms. Established for many years as a link between the healthcare industry and the financial markets, MC Services provides comprehensive services in investor relations, public relations and financial transactions. MC Services is based in Munich, Düsseldorf, London and Boston.

www.mc-services.eu

IP_left_purple.jpg

Instinctif Partners provides a full service communications consultancy focused on science-based sectors.

65 Gresham Street
London
EC2V 7NQ

Tel: +44 (0) 20 7457 2020 

www.lifesciences.instinctif.com

Instinctif Partners 

Instinctif Partners is an international business communications consultancy. Over three decades we have built a track record of delivering strategic counsel and insightful and creative programmes, focused on enhancing the value proposition for companies seeking investment, partnerships or customers. Our core skill is working with clients to communicate the value of their science and innovation to key stakeholders through the most relevant channels: crafting communications solutions that showcase each company, product or technology. Specifically, we are unique in offering specialist expertise seamlessly across corporate, financial, healthcare and marketing communications with outreach programmes to media, industry, professional, public, financial and investment communities. Headquartered in London, our globally integrated and dedicated life sciences team serves clients around the world from our bases in the EU, the US and Asia Pacific.

www.lifesciences.instinctif.com

NIBC_Logo.png

https://www.nibc.com/solutions/

 

NIBC Bank N.V.

NIBC offers corporate and investment banking services to mid-market clients in Europe. In August 2017, the bank expanded its focus sectors with Life Sciences when Oscar Izeboud and Jean-Paul Mannie joined the firm. Their extensive transaction track record in Equity Capital Markets and M&A builds on years of experience and strong ties to the international biotech community. The Life Sciences team at NIBC can offer the full range of advisory and financing services, from ECM, M&A to mezzanine equity and leveraged and senior debt. This integrated multi-product approach results in tailor-made solutions for our clients in their decisive financial moments. For an overview of solutions that NIBC offers, please have a look at: https://www.nibc.com/solutions/

shore_capital.jpg

Shore Capital Markets, a division
of Shore Capital Group, is an independent securities business with a large and extensive research and sales capability offering comprehensive distribution to institutions and mid and small cap companies.

Bidhi Bhoma
Director, Investment
Banking - Healthcare
Tel: +44 (0) 20 7468 7904

Dr Tara Raveendran
Healthcare Research
Tel: +44 (0) 20 7647 8142

www.shorecapmarkets.co.uk

Shore Capital 

Shore Capital Markets, a division of Shore Capital Group, is a leading independent securities business offering institutional and corporate clients leading investment banking, research, sales and trading services. 

We are represented across the UK, offering extensive research and sales capability, and comprehensive distribution to institutions and mid and small-cap companies. This distribution capability is complemented by our experienced Corporate Broking & Advisory team, who are dedicated to offering innovative and valued advice to companies on both the Main Market and AIM.

Shore Capital Markets is also one of the largest market makers in the London market; it is the third largest market maker on AIM by volume of trades. Shore Capital Markets has been involved in transactions raising more than £5.5bn in equity capital markets since January 2014.

Shore Capital’s Healthcare team provides comprehensive research coverage across the entire UK healthcare spectrum. This includes major pharma, specialty pharma, medical devices, life sciences and healthcare services. Our research product provides our clients with detailed, insightful analysis, with a particular focus on in-depth, high quality research. Healthcare research is distributed to over 300 UK and European institutions via our highly experienced sales people, including two healthcare specialists. 

www.shorecapmarkets.co.uk

panmuregordon.png

Panmure is a corporate and institutional stockbroker and investment bank.

Panmure Gordon & Co
One New Change
London
EC4M 9AF

Tel: +44 (0) 20 7886 2500

www.panmure.com 
@PanmureGordon

Panmure Gordon

Panmure Gordon is a leading independent stockbroker and investment bank specialising in corporate advice, M&A and institutional investment for the UK’s most ambitious and successful companies. Our deep healthcare knowledge and expertise has assisted clients to IPO, raise development capital and complete successful M&A transactions.

Our clients value our breadth of sector knowledge, track record and tailored, integrated service that is relationship led and outcome driven.

www.panmure.com

 peelhunt.png

Peel Hunt is an independent, full-service specialist broking and advisory house, focused on UK mid and small caps, with a leading Healthcare and Life Sciences franchise.

Moor House
120 London Wall
London
EC2Y 5ET

Tel: +44 (0) 20 7418 8900
Fax: +44 (0) 20 7418 8848

info@peelhunt.com
www.peelhunt.com

Peel Hunt 

Peel Hunt is an independent, full-service specialist broking and advisory house with a focus on UK mid and small-cap companies. Our partnership structure, over 25 years of profitability, extensive trading platform and focus on long-term client relationships set us apart from our peers. We have expertise across a broad range of sectors and seek to offer high quality advice, ideas-led research and flawless execution within a team-based and collegiate environment. Peel Hunt benefits from a powerful distribution platform and since 2015 we have completed over 100 ECM transactions (including 23 IPOs). We have over 115 retained corporate clients and continue to grow strongly.

Our Healthcare and Life Sciences team comprises dedicated sector specialists across research, sales and corporate with unparalleled access to small, mid and larger-cap investors across the UK, Europe and North America. In recent years Peel Hunt has raised over £1bn for its healthcare clients and we represent companies in the sector with an aggregate market capitalisation of over £4bn.

www.peelhunt.com 
Peel Hunt LLP is authorised and regulated by the Financial Conduct Authority.

Northland_logo_vert.jpg

60 Gresham Street 
4th Floor
London 
EC2V 7BB

Tel: +44 (0) 20 3861 6625
Fax: +44 (0) 20 7600 5975 

info@northlandcp.co.uk

Northland Capital Partners

Northland Capital Partners is a well-established independent institutional stockbroker and corporate finance adviser. We provide broking and advisory services to quoted growth companies and facilitate access to capital.

Driven by our broad network of investors, and wide expertise across multiple sectors, our team has established a proven track record in raising funds for corporate clients. We pride ourselves on a commercial approach which ensures that our clients achieve their growth ambitions.

Northland recently strengthened its offering with a co-operation agreement with stockbroking partnership, Baden Hill. The agreement extends Northland’s capability further across corporate finance, corporate broking, institutional sales, and sales-trading execution services. 

www.northlandcp.co.uk

DP_sponsor_logo_EMA17.png 

7 Ensign House
Admirals Way
London
E14 9XQ

Tel: +44 (0)20 7536 2000 

www.design-portfolio.co.uk
@WeAre_DP

Design Portfolio

For over 25 years Design Portfolio has been helping quoted companies communicate effectively and efficiently. We consult with and support a wide variety of corporate clients from FTSE 100 to AIM, as well as private companies and those new to market. Sectors in which we can demonstrate specialist knowledge include life sciences, healthcare, medtech and biotech. 

We work in print, digital and moving image across six core areas: 

  • Annual reports 
  • Investor presentations 
  • Corporate websites 
  • Video and animation 
  • Sustainability communications 
  • Corporate branding 
Our blend of considered creativity and expert consultancy is delivered by expert teams through a local, personal and hands-on service with offices in London, Leeds, Cambridge, Edinburgh and Miami. 

www.design-portfolio.co.uk 
@WeAre_DP

 Supported by: 

 

 biocentury.jpg

Main Office
1235 Radio Road 
Ste. 100
Redwood City
CA 94065-1217

Tel: +1 650-595-5333
Tel: +1 650-595-5589

www.biocentury.com

 

 

Biocentury 

Since 1993, BioCentury Inc. has been internationally recognised as the leading provider of value-added information, analysis and data for biotechnology and pharmaceutical companies, investors, academia and Government on the strategic issues essential to the formation, development and sustainability of life science ventures.

BioCentury employs a fully integrated multimedia platform – including publications, online data solutions, conferences and eLearning programmes – to provide its audience with authoritative and up-to-date intelligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets.

The company publishes the weekly editions of its flagship publication, BioCentury®, and BioCentury Week in Review, plus daily editions of BioCentury Extra. BioCentury also publishes BioCentury Innovations, a weekly translational science journal.

The company also markets BCIQ, the industry's premiere business intelligence and research database. It provides easy access to data on thousands of companies and products and $400+bn in financings.

www.biocentury.com

lsp_082006.jpg

LSP is one of the world's largest specialised healthcare and biotechnology investment firms.

Johannes Vermeerplein 9 
1071 DV Amsterdam 
Netherlands 

Tel: +31 (0) 20 664 5500 
Fax: +31 (0) 20 676 8810

lspamsterdam@lspvc.com
www.lspvc.com

LSP

With offices in Amsterdam, Munich and Boston, LSP has successfully invested in the healthcare and biotechnology sectors for over two decades. Since its inception in the late 80s, LSP has invested in a large number of both privately held and publicly traded life science companies, many of which have become leaders in their respective industries.

www.lspvc.com

onenucleus.png

Cambridge (Head Office) 
The Portway
Granta Park
Cambridge
CB21 6GS 

Tel: +44 (0) 1223 896 450
Fax: +44 (0) 1223 896 471

info@onenucleus.com
www.onenucleus.com

One Nucleus 

One Nucleus is an international membership organisation for life science and healthcare companies. We are based in Cambridge with the majority of our members across the Cambridge/London corridor – at the heart of Europe’s largest life science and healthcare cluster. We have over 470 organisations as members, including pharmaceutical, biotech, medical device and diagnostic companies and associated technical and commercial service providers.

One Nucleus’ mission is to maximise the global competitiveness of our members. For our science and technology-based members, that means them being global leaders in the research, development and commercialisation of healthcare innovations that radically improve the quality of people’s lives around the world. For our business and professional services members, it means them delivering exceptional services that significantly enhance the business performance of their clients.

Collectively, the membership forms a commercial, clinical and academic powerhouse. Around 80% of our members are based in the Cambridge/London corridor, an area which is home to at least 60% of the UK’s life science industry base.

With our critical mass of membership (being the largest in Europe by some way), as well as the services we offer, the member benefits include:

  • A large and significant pool of companies to support business-to-business interaction within the membership.
  • Membership of a cluster of international size, relevance and visibility. 
  • Major impact both in the UK and overseas with the compelling excellence of our members articulated strongly to international organisations, institutions and Governments for ultimate member benefit.

www.onenucleus.com